Last reviewed · How we verify

NCT07256145

Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia

Recruiting now NA Last updated 1 December 2025
What this trial tests

NA trial testing erector spinae plane block in Post-Herpetic Neuralgia in 60 participants. Currently enrolling.

Timeline
1 August 2025
Primary endpoint
1 February 2026
1 March 2026

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date1 August 2025
Primary completion1 February 2026
Estimated completion1 March 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 20 to 70, any sex, with Post-Herpetic Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of erector spinae plane block

Trials testing the same drug.

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07256145.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing